Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04066595
Title Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma. (CabUC)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johannes Gutenberg University Mainz
Indications

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.